Gain Therapeutics KOL Event on Gaucher and GBA1 Parkinson’s Disease
About The Event
The webinar will feature a presentation from Frances Platt, Ph.D., FMedSci, FRS (University of Oxford) and Ricardo A. Feldman, Ph.D. (University of Maryland School of Medicine) who will discuss the current treatment landscape and unmet medical need in treating patients with Gaucher and GBA1 Parkinson’s Disease, and recently released pre-clinical data. Joanne Taylor, PHD (Chief Scientific Advisor at Gain Therapeutics) will moderate the webinar. Gain’s scientific leadership team will also provide a brief update on their proprietary platform.
Gain Therapeutics is redefining drug discovery with its SEE-Tx™ target identification platform. By identifying and optimizing allosteric binding sites that have never before been identified, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein mis-folding.
A question and answer session will follow the formal presentations.